The Risk of Emerging Resistance to Trimethoprim/Sulfamethoxazole in Staphylococcus aureus

References

• DeLeo FR, Otto M, Kreiswirth BN, Chambers HF. Community-associated methicillin-resistant Staphylococcus aureus. Lancet. 2010;375:1557–1568. doi:10.1016/S0140-6736(09)61999-1
   PubMed Web of Science ®Google Scholar
• David MZ, Daum RS. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev. 2010;23:616–687. doi:10.1128/CMR.00081-09
   PubMed Web of Science ®Google Scholar
• Algammal AM, Hetta HF, Elkelish A, et al. Methicillin-Resistant Staphylococcus aureus (MRSA): one health perspective approach to the bacterium epidemiology, virulence factors, antibiotic-resistance, and zoonotic impact. Infect Drug Resist. 2020;13:3255–3265. doi:10.2147/IDR.S272733
   PubMed Web of Science ®Google Scholar
• Spengler G, Gajdács M, Donadu MG, et al. Evaluation of the antimicrobial and antivirulent potential of essential oils isolated from Juniperus oxycedrus L. ssp. macrocarpa aerial parts. Microorganisms. 2022;10(4):758. doi:10.3390/microorganisms10040758
   PubMed Web of Science ®Google Scholar
• Mazzarello V, Gavini E, Rassu G, et al. Clinical assessment of new topical cream containing two essential oils combined with tretinoin in the treatment of acne. Clin Cosmet Investig Dermatol. 2020;13:233–239. doi:10.2147/CCID.S236956
   Web of Science ®Google Scholar
• Bua A, Usai D, Donadu MG, et al. Antimicrobial activity of Austroeupatorium inulaefolium (H.B.K.) against intracellular and extracellular organisms. Nat Prod Res. 2018;32:2869–2871. doi:10.1080/14786419.2017.1385014
   PubMed Web of Science ®Google Scholar
• Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52:e18–e55. doi:10.1093/cid/ciq146
   PubMed Web of Science ®Google Scholar
• Spellberg B, Lipsky BA. Systemic antibiotic therapy for chronic osteomyelitis in adults. Clin Infect Dis. 2012;54:393–407. doi:10.1093/cid/cir842
   PubMed Web of Science ®Google Scholar
• Paul M, Bishara J, Yahav D, et al. Trimethoprim-sulfamethoxazole versus vancomycin for severe infections caused by meticillin resistant Staphylococcus aureus: randomised controlled trial. BMJ. 2015;350:h2219. doi:10.1136/bmj.h2219
   PubMed Web of Science ®Google Scholar
• Schmitz GR, Bruner D, Pitotti R, et al. Randomized controlled trial of trimethoprim-sulfamethoxazole for uncomplicated skin abscesses in patients at risk for community-associated methicillin-resistant Staphylococcus aureus infection. Ann Emerg Med. 2010;56:283–287. doi:10.1016/j.annemergmed.2010.03.002
   PubMed Web of Science ®Google Scholar
• Dale GE, Broger C, D’Arcy A, et al. A single amino acid substitution in Staphylococcus aureus dihydrofolate reductase determines trimethoprim resistance. J Mol Biol. 1997;266:23–30. doi:10.1006/jmbi.1996.0770
   PubMed Web of Science ®Google Scholar
• Nurjadi D, Olalekan AO, Layer F, et al. Emergence of trimethoprim resistance gene dfrG in Staphylococcus aureus causing human infection and colonization in sub-Saharan Africa and its import to Europe. J Antimicrob Chemother. 2014;69:2361–2368. doi:10.1093/jac/dku174
   Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria. CLSI Guideline M45. 3rd ed. Wayne, PA: CLSI; 2016.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. CLSI Supplement M100. 28th ed. Wayne, PA: CLSI; 2018.
   Google Scholar
• Berti AD, Wergin JE, Girdaukas GG, Hetzel SJ, Sakoulas G, Rose WE. Altering the proclivity towards daptomycin resistance in methicillin-resistant Staphylococcus aureus using combinations with other antibiotics. Antimicrob Agents Chemother. 2012;56:5046–5053. doi:10.1128/AAC.00502-12
   PubMed Web of Science ®Google Scholar
• Dale GE, Then RL, Stüber D. Characterization of the gene for chromosomal trimethoprim-sensitive dihydrofolate reductase of Staphylococcus aureus ATCC 25923. Antimicrob Agents Chemother. 1993;37:1400–1405. doi:10.1128/AAC.37.7.1400
   Web of Science ®Google Scholar
• Saito M, Katayama Y, Hishinuma T, et al. “Slow VISA”, a novel phenotype of vancomycin resistance, found in vitro in heterogeneous vancomycin-intermediate Staphylococcus aureus strain Mu3. Antimicrob Agents Chemother. 2014;58:5024–5035. doi:10.1128/AAC.02470-13
   Web of Science ®Google Scholar
• Sader HS, Mendes RE, Streit JM, Flamm RK. Antimicrobial susceptibility trends among staphylococcus aureus isolates from U.S. hospitals: results from 7 years of the ceftaroline (AWARE) surveillance program, 2010 to 2016. Antimicrob Agents Chemother. 2017;61:e01043–17. doi:10.1128/AAC.01043-17
   Web of Science ®Google Scholar
• Watanabe S, Ohnishi T, Yuasa A, et al. The first nationwide surveillance of antibacterial susceptibility patterns of pathogens isolated from skin and soft-tissue infections in dermatology departments in Japan. J Infect Chemother. 2017;23:503–511. doi:10.1016/j.jiac.2017.05.006
   Web of Science ®Google Scholar
• Kavanagh N, Ryan EJ, Widaa A, et al. Staphylococcal osteomyelitis: disease progression, treatment challenges, and future directions. Clin Microbiol Rev. 2018;31:e00084–17. doi:10.1128/CMR.00084-17
   PubMed Web of Science ®Google Scholar
• Song LY, Goff M, Davidian C, et al. Mutational consequences of ciprofloxacin in Escherichia coli. Antimicrob Agents Chemother. 2016;60:6165–6172. doi:10.1128/AAC.01415-16
   Web of Science ®Google Scholar
• Ward WO, Swartz CD, Hanley NM, DeMarini DM. Transcriptional characterization of Salmonella TA100 in log and stationary phase: influence of growth phase on mutagenicity of MX. Mut Res. 2010;692:19–25. doi:10.1016/j.mrfmmm.2010.07.010
   Web of Science ®Google Scholar
• Holmes AH, Moore LS, Sundsfjord A, et al. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet. 2016;387:176–187. doi:10.1016/S0140-6736(15)00473-0
   PubMed Web of Science ®Google Scholar
• Durão P, Balbontín R, Gordo I. Evolutionary mechanisms shaping the maintenance of antibiotic resistance. Trends Microbiol. 2018;26:677–691.
   PubMed Web of Science ®Google Scholar
• Aires de Sousa M, Crisóstomo MI, Sanches IS, et al. Frequent recovery of a single clonal type of multidrug-resistant Staphylococcus aureus from patients in two hospitals in Taiwan and China. J Clin Microbiol. 2003;41:159–163. doi:10.1128/JCM.41.1.159-163.2003
   Web of Science ®Google Scholar
• Breurec S, Fall C, Pouillot R, et al. Epidemiology of methicillin-susceptible Staphylococcus aureus lineages in five major African towns: high prevalence of Panton-Valentine leukocidin genes. Clin Microbiol Infect. 2011;17:633–639. doi:10.1111/j.1469-0691.2010.03320.x
   PubMed Web of Science ®Google Scholar
• Olalekan AO, Schaumburg F, Nurjadi D, et al. Clonal expansion accounts for an excess of antimicrobial resistance in Staphylococcus aureus colonising HIV-positive individuals in Lagos, Nigeria. Int J Antimicrob Agents. 2012;40:268–272. doi:10.1016/j.ijantimicag.2012.05.016
   Web of Science ®Google Scholar
• Coelho C, de Lencastre H, Aires-de-Sousa M. Frequent occurrence of trimethoprim-sulfamethoxazole hetero-resistant Staphylococcus aureus isolates in different African countries. Eur J Clin Microbiol Infect Dis. 2017;36:1243–1252. doi:10.1007/s10096-017-2915-x
   PubMed Web of Science ®Google Scholar
• Donadu MG, Ferrari M, Mazzarello V, et al. No correlation between biofilm-forming capacity and antibiotic resistance in environmental Staphylococcus spp. In Vitro Results Pathogens. 2022;11:471. doi:10.3390/pathogens11040471
   Web of Science ®Google Scholar
• Giacinti G, Carfora V, Caprioli A, et al. Prevalence and characterization of methicillin-resistant Staphylococcus aureus carrying mecA or mecC and methicillin-susceptible Staphylococcus aureus in dairy sheep farms in central Italy. J Dairy Sci. 2017;100:7857–7863. doi:10.3168/jds.2017-12940
   Web of Science ®Google Scholar
• Sato T, Kawamura M, Furukawa E, Fujimura S. Screening method for trimethoprim/sulfamethoxazole-resistant small colony variants of Staphylococcus aureus. J Glob Antimicrob Resist. 2018;15:1–5. doi:10.1016/j.jgar.2018.05.008
   Web of Science ®Google Scholar